Ceram Publishes New White Paper on Multi-Substituted Hydroxyapatite
As part of our ongoing work on biocompatibility and bioactivity of Hydroxyapatite (HA), we have published a new white paper, ‘Multi-Substituted Hydroxyapatites and the Role They Can Play in Enhanced Bone Replacement Solutions'.
The white paper, whilst giving a brief introduction of the opportunities for synthetic HA (and associated structures) in bone replacement, focuses on substituted Hydroxyapatite. Some results from a recently completed study on multi-substituted HA - carried out to find out how mean ionic volume and charge impact on the yield of the crystalline HA - are discussed. All HA work reported is based on computer controlled wet precipitation production routes under mild conditions that should be scalable.
With our newly-patented technology, Ceram's aim is to work with clients to develop HA with tailored bioactivity, both for bone replacement materials applications and for new drug delivery systems with tailored bio-application requirements.
The white paper is free to download via the panel to the right of this page.